Trial Details
RecruitingBasic Information
| Clinical ID | c2594 |
|---|---|
| Identifier | CTRI/2019/11/022087 |
| Trial Title | A Study to Assess the Effect of a Probiotic Strains (Bacillus clausii) on Gut Microbiota and Mucosal Immunity in Inflammatory Bowel Disease - EPMIBD |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Health Condition 1: null- Inflammatory Bowel Disease -Ulcerative Colitis and Crohns disease_Health Condition 2: K638- Other specified diseases of intestine_ |
| Interventions | Intervention1: Casule of Bacillus clausii UBBC07(Probiotic CFU-2X109 per capsule): Dose - Probiotic CFU- 2X109 per capsule Frequency- BD (One probiotic capsule twice in day) (Probiotic CFU- 2X109 per capsule) Duration of intervention - 4 Week Route of administration-Oral Intervention2: Bacillus coagulans Unique IS2(Probiotic CFU-2X109 per capsule): Dose - Probiotic CFU- 2X109 per capsule Frequency- BD (One probiotic capsule twice in day) (Probiotic CFU - 2X109 per capsule)Duration of intervention - 4 Week Route of administration-Oral Control Intervention1: Nil: Nil |
Participant Information
| Sponsor | Unique Biotech |
|---|---|
| City | - |
| Country/Region | India |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |